The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 375.00
Bid: 360.00
Ask: 374.00
Change: 11.00 (3.02%)
Spread: 14.00 (3.889%)
Open: 375.00
High: 375.00
Low: 375.00
Prev. Close: 364.00
WIL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on COVID-19 Coronavirus Impact and Dividend

25 Mar 2020 07:00

RNS Number : 4671H
Wilmington PLC
25 March 2020
 

25 March 2020

Wilmington plc

('Wilmington', 'the Group' or 'the Company')

Update on COVID-19 Coronavirus Impact and Dividend

 

Wilmington plc, the provider of data, information, education and networking events in Risk & Compliance, Healthcare and Professional knowledge areas, today announces a further update on the potential impact of COVID-19 ("Coronavirus").

 

The Group continues to closely monitor the developing situation regarding Coronavirus and the advice and directives from governments, the World Health Organisation and other relevant agencies. The health and safety of our employees, customers and partners remains the Group's main priority.

 

Operational Update

 

All parts of the Group are working remotely, with full operational capabilities currently being maintained through the investments in IT infrastructure and digital solutions that the Group has made over the last few years. Whilst the internal response has been swift and a testament to the professionalism of our employees, there is no doubt that the external impacts on parts of our business are now material. The recent restrictions placed on the congregation and movement of individuals by governments in Europe and the US are, by their nature, having an impact on the Group's ability to run conferences, events and face-to-face training courses.

 

Networking events - which typically account for c.15% of annual Group revenues

Currently the Group has suspended all face-to-face conferences and events until further notice. We are not planning to run any face-to-face events prior to 1 July, other than a handful of events such as RISE Nashville that were originally due to run in March and where delegates and sponsors are already signed up. These are currently scheduled to run in late June. We will review the feasibility of these current plans as the situation develops.

 

Where possible we are converting elements of postponed events to run in an online format. There has been demand for such developments in a number of our communities and we are actively seeking to support them at this time.

 

Education and training - which typically accounts for c.40% of annual Group revenues

The Group has currently suspended all face-to-face training in Europe, the US and Asia until further notice. The Group has made significant progress over the last few years enhancing its capability to deliver a variety of digital learning solutions. Prior to the outbreak of Coronavirus around a third of Group training was delivered digitally, often as part of a blended solution. Demand for this has increased notably over recent weeks, and the Group is meeting this demand with a range of novel and innovative solutions.

 

Information and Data - which typically accounts for c.45% of annual Group revenues

We are seeing no material impact on demand for data and information products. 65% of data and information products are sold via subscription, typically on an annual basis.

 

In total, the Group currently believes that between £12m and £17m of previously anticipated revenue for this financial year is at risk. The range is primarily dependent on whether the June events run and the extent to which face-to-face events and training can be converted to digital variants. Direct and other cost mitigations, totalling between £5.5m and £7m, are similarly anticipated. These adjustments would result in an expected adjusted PBT for the year ended 30 June 2020 of between £8.5m and £12m. Timescales for recovery and overall impacts are impossible to predict currently, and the Group is therefore suspending all other formal guidance at this time.

 

Net debt and dividend

 

The Board is taking steps at this stage to review cash commitments, including reviewing all discretionary operating and capital expenditure. In light of these exceptional circumstances, the Board has taken the difficult decision to cancel the interim dividend of 4.2p that was due to be paid on 9 April 2020. The cash saving of this decision will be £3.6m. The Board remains committed to a resumption of dividends as soon as the trading environment normalises.

The Group has significant current liquidity, with £10m of cash and undrawn bank facilities of £16m. Our cashflow modelling, including scenarios which assume no face-to-face events or training from now until the end of August, indicates that the Group would remain within facility limits. The Board is mindful that events out of the control of the Company continue to evolve at pace. It is monitoring the balance sheet carefully and has had proactive and constructive dialogue with its banks regarding covenant headroom and facility limits. We will update shareholders accordingly.

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Richard Amos, Chief Financial Officer

 

FTI Consulting

Charles Palmer / Dwight Burden / Emma Hall / Leah Dudley

 

 

020 7490 0049

 

 

 

020 3727 1000

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFFFIIVEISFII
Date   Source Headline
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company
20th Feb 20237:00 amRNSHalf-year Report
9th Feb 202312:36 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSNotice of Half Year-End Results
19th Dec 202211:32 amRNSHolding(s) in Company
12th Dec 20227:00 amRNSJoint Broker appointment
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:50 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
23rd Nov 20223:12 pmRNSResult of AGM
15th Nov 20222:31 pmRNSHolding(s) in Company
17th Oct 202212:11 pmRNSHoling(s) in Company
17th Oct 202212:11 pmRNSHolding(s) in Company
3rd Oct 20225:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20224:42 pmRNSSecond Price Monitoring Extn
30th Sep 20224:36 pmRNSPrice Monitoring Extension
29th Sep 20223:43 pmRNSHolding(s) in Company
29th Sep 20223:36 pmRNSIssue of ordinary shares
22nd Sep 20227:00 amRNSFinancial results for the year ended 30 June 2022
31st Aug 20227:00 amRNSNotice of Results
19th Aug 20225:07 pmRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSTotal Voting Rights
27th Jul 20227:00 amRNSYear-End Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.